Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País como asunto
Tipo del documento
Publication year range
1.
Burns ; 50(5): 1062-1067, 2024 06.
Artículo en Inglés | MEDLINE | ID: mdl-38402119

RESUMEN

AIM: This paper describes how Singapore achieved skin allograft self-sufficiency in 2017 by adopting 5 key strategies in 2012. BACKGROUND: Singapore General Hospital (SGH) established its own allograft recovery programme in 1998 but was still dependent on overseas allograft procurement. KEY STRATEGIES: RESULTS: The allograft recovery programme expanded from 4 to all 20 institutions. Donor referrals increased by 42.9% from 35 in 2014 to over 50 currently. Donor numbers increased by 210%, rising from 4.5 per year before 2015 to an average of 14 per year from 2015 to 2022. The total allografts recovered increased by 223%, climbing from 13,000 to 42,000 annually. Cryopreservation was adopted, extending shelf life to 5.5 years and doubling storage capacity to more than 140,000 cm2 in 2022. CONCLUSION: Singapore achieved skin allograft self-sufficiency with no overseas procurement since 2017.


Asunto(s)
Aloinjertos , Quemaduras , Criopreservación , Trasplante de Piel , Obtención de Tejidos y Órganos , Humanos , Singapur , Trasplante de Piel/métodos , Quemaduras/cirugía , Obtención de Tejidos y Órganos/organización & administración , Obtención de Tejidos y Órganos/métodos , Donantes de Tejidos , Trasplante Homólogo , Derivación y Consulta
2.
Phlebology ; 36(7): 515-525, 2021 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-33593122

RESUMEN

OBJECTIVE: This study assessed the improvement in Quality of Life (QoL) of Chronic Venous Disease (CVD) patients in Sri Lanka following treatment. METHODS: This was a prospective observational study of 58 newly or previously diagnosed CVD patients. QoL was assessed by the 14-item ChronIc Venous dIsease quality of life Questionnaire (CIVIQ-14) at 4 and 8 weeks after treatment. RESULTS: At 8 weeks, the improvement in Global score from baseline was greatest in the surgical group with adjusted least squares mean of 23.5 (p < 0.001) followed by the non-surgical group at 13.3 (p < 0.001). There was no significant improvement in the no-treatment group at 0.333 (p = 0.950). Similar results were obtained for Pain and Physical domain scores at 8 weeks. Likewise, at 4 weeks, Global score and Pain and Physical domain scores showed significant improvement in the surgical and non-surgical groups (all p < 0.001) only. CONCLUSION: Both surgical and non-surgical treatments improved QoL of CVD patients.


Asunto(s)
Calidad de Vida , Insuficiencia Venosa , Enfermedad Crónica , Humanos , Sri Lanka , Encuestas y Cuestionarios , Insuficiencia Venosa/terapia
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda